Among numerous genes known to be associated with T2D risk, mRNA expression of TFAP2A was higher in skeletal muscle tissues [19], blood [20], and liver [21] of patients suffering from T2D or a prediabetic phenotype identified as insulin-resistant. This evidence concerns the gene TFAP2A and type 2 diabetes mellitus.